NasdaqCM - Delayed Quote USD
Traws Pharma, Inc. (TRAW)
1.1900
+0.0700
+(6.25%)
At close: May 16 at 4:00:01 PM EDT
1.2900
+0.10
+(8.40%)
After hours: May 16 at 7:54:51 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-29,792
-29,792
-17,932
-16,294
-19,487
Investing Cash Flow
-3,648
-3,648
-14
0
0
Financing Cash Flow
33,976
33,976
0
0
55,560
End Cash Position
21,338
21,338
20,821
38,757
55,070
Capital Expenditure
--
--
-14
--
--
Issuance of Capital Stock
33,976
33,976
0
0
55,041
Free Cash Flow
-29,792
-29,792
-17,946
-16,294
-19,487
12/31/2021 - 7/25/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RLMD Relmada Therapeutics, Inc.
0.4610
+11.51%
ENTO Entero Therapeutics, Inc.
0.4243
-1.33%
ASBP Aspire Biopharma Holdings, Inc.
0.2490
+7.47%
MEIP MEI Pharma, Inc.
2.0800
-1.42%
NBY NovaBay Pharmaceuticals, Inc.
0.5900
+1.72%
SABS SAB Biotherapeutics, Inc.
1.8500
-4.64%
LYRA Lyra Therapeutics, Inc.
0.1117
-0.98%
TSBX Turnstone Biologics Corp.
0.3352
-5.58%
EYEN Eyenovia, Inc.
1.1300
0.00%
APM Aptorum Group Limited
0.9521
+0.97%